Ophthalmological Adverse Events of Tralokinumab in AD

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

March 31, 2026

Conditions
Atopic Dermatitis
Trial Locations (11)

Unknown

CHU de Bordeaux, Bordeaux

CHU de Brest, Brest

CHU de Clermont Ferrand, Clermont-Ferrand

CHu de Dijon, Dijon

CHRU de Lille, Lille

Hospice Civil de Lyon, Lyon

CHU de Nantes, Nantes

Hôpital Saint Louis, Paris

CHu de Poitiers, Poitiers

CHu de Rennes, Rennes

CHU de Rouen, Rouen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

lead

Nantes University Hospital

OTHER